Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leu
- PDF / 1,846,816 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 34 Downloads / 161 Views
ORIGINAL ARTICLE
Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all‑trans retinoic acid and chemotherapy Hideho Henzan1 · Ken Takase2 · Tomohiko Kamimura3 · Yasuo Mori4 · Goichi Yoshimoto4 · Hiromi Iwasaki2 · Koji Nagafuji5 · Ryosuke Ogawa6 · Tetsuya Eto1 · Naoyuki Uchida7 · Tomoaki Fujisaki8 · Koji Kato4 · Mariko Minami2,4 · Yoshikane Kikushige4 · Koichi Akashi4 · Toshihiro Miyamoto4 · for the Fukuoka Blood & Marrow Transplantation Group (FBMTG) Received: 10 February 2020 / Revised: 4 May 2020 / Accepted: 27 May 2020 © Japanese Society of Hematology 2020
Abstract We stratified patients with newly diagnosed acute promyelocytic leukemia (APL) according to a white blood cell (WBC) count of ≥ 3 × 109/L (high risk) or
Data Loading...
